Group One Trading
CYTO

Group One Trading’s Altamira Therapeutics Ltd CYTO Stock Holding History

Group One Trading’s Portfolio CYTO Stock Details CYTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-17
Closed -$7K – 8766
2022
Q1 		$7K Sell
17
-65
-79% -$31.4K ﹤0.01% 7339
2021
Q4 		$59K Buy
82
+70
+583% +$46.9K ﹤0.01% 6196
2021
Q3 		$10K Sell
12
-11
-48% -$12.4K ﹤0.01% 7519
2021
Q2 		$33K Sell
23
-5
-18% -$6.86K ﹤0.01% 6903
2021
Q1 		$38K Buy
+28
New +$37.5K ﹤0.01% 6413
2016
Q4 		– Hold
0
– -$9K – 4946
2016
Q3 		– Hold
0
– – – 4084

Other funds holding CYTO

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's CYTO Position: Q4 2024 in Review

Group One Trading sold out of Altamira Therapeutics Ltd (CYTO) in Q4 2024, closing a stake of 14 shares — an estimated $9 sold.

Group One Trading first reported a position in CYTO in Q1 2021 and held it in 14 quarters. The position peaked at $94K in Q4 2021. 2 funds tracked by Wall St. Rank hold CYTO as of Q4 2024.

  • Group One Trading reported no remaining Altamira Therapeutics Ltd position as of Q4 2024 after selling out during the quarter.
  • Group One Trading sold 14 Altamira Therapeutics Ltd shares in Q4 2024, an estimated $9.
  • Group One Trading first reported a position in Altamira Therapeutics Ltd in Q1 2021 and held it in 14 quarters.
  • Group One Trading's Altamira Therapeutics Ltd position peaked at $94K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Altamira Therapeutics Ltd as of Q4 2024.

Based on Group One Trading's 13F filing for Q4 2024, filed 14 Feb 2025.